Clinical Trial Update: Evaluation of Platelet Rich Fibrin Matrix as Regenerative Material in Intraosseous Defects [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating platelet-rich fibrin matrix as a regenerative material for intraosseous defects has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Regenerative Inflammation

Drugs mentioned

• Platelet Rich Fibrin Matrix

Snippet

Sponsor: KLE Society's Institute of Dental Sciences | Conditions: Regenerative Inflammation | Phase 3 | Status: COMPLETED